NATI-FabNCT07872852
Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With Fabry Disease (FD)
StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Proportion of non-treated non-hypertrophic Fabry females for whom the indication for specific Fabry therapy (ERT or chaperone) is modified (i.e. established) based on additional information provided by low native myocardial T1 value.
Timeframe: Month 12
Secondary (4)
Association of low native T1 value with phenotype
Association of low native T1 value with genotype
Association of low native T1 value with cardiac status
Disease progression
Arms and interventions
CMR low native myocardial T1 valueExperimental
Potential therapeutic impact of CMR myocardial native T1
Other: Decision tree for initiating treatment
Sites
12 sites in 1 country